Lisata Therapeutics Inc (LSTA)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Lisata Therapeutics Inc-Aktie (LSTA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	0.07	-	1.00	-
Operating Expenses	10.61% 4.414	4.938	5.847	5.949	5.336
Benefits Costs and Expenses	10.15% 4.249	4.729	5.686	-	-
Costs And Expenses	10.15% 4.249	4.729	5.686	-	-
Depreciation and Amortization	0.00% 0.044	0.044	0.043	0.041	0.042
Operating Income/Loss	9.33% -4.414	-4.868	-5.847	-4.949	-5.336
Nonoperating Income/Loss	21.05% 0.165	0.209	0.161	0.339	0.406
Income/Loss From Equity Method Investments	-	-	-	-	-0.03
Income/Loss From Continuing Operations Before Tax	8.80% -4.249	-4.659	-5.686	-4.61	-4.93
Income Tax Expense/Benefit	-	-	-0.962	-	-
Income/Loss From Continuing Operations After Tax	8.80% -4.249	-4.659	-4.724	-4.61	-4.93
Net Income/Loss	8.80% -4.249	-4.659	-4.724	-4.61	-4.93
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.55% 8.738	8.605	8.602	0.022	8.321
Diluted Average Shares	1.55% 8.738	8.605	8.602	0.022	8.321
Basic Earnings Per Share	9.26% -0.49	-0.54	-0.55	-0.55	-0.59
Diluted Earnings Per Share	9.26% -0.49	-0.54	-0.55	-0.55	-0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%